# iRhythm Holdings to Report First Quarter 2026 Financial Results on April 30, 2026
Canonical URL: https://biopharmsignal.com/news/IRTC/irhythm-holdings-to-report-first-quarter-2026-financial-results-on-april-30-2026-423427e1
Ticker: IRTC
Company: iRhythm
Source: iRhythm
Published: 2026-04-16 20:05 EST
## Summary

iRhythm Holdings, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted...

## Article Body
iRhythm Holdings, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that it will release financial results for the first quarter 2026 after the close of trading on Thursday, April 30, 2026. The company’s management team will host a corresponding conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET.

Interested parties may access a live and archived webcast of the conference call on the “Quarterly Results” section of the company’s investor website at investors.irhythmtech.com .

About iRhythm Holdings, Inc. iRhythm is a leading digital health care company that creates trusted solutions that detect, predict, and prevent disease. Combining wearable biosensors and cloud-based data analytics with powerful proprietary algorithms, iRhythm distills data from millions of heartbeats into clinically actionable information. Through a relentless focus on patient care, iRhythm’s vision is to deliver better data, better insights, and better health for all.

Investor Contact investors@irhythmtech.com

Media Contact Kassandra Perry mediarelations@irhythmtech.com
## Recent Company News
- 2026-07-16 20:05 EST — [iRhythm Holdings to Report Second Quarter 2026 Financial Results on August 6, 2026](https://biopharmsignal.com/news/IRTC/irhythm-holdings-to-report-second-quarter-2026-financial-results-on-august-6-202-c95df473) — Source: iRhythm
- 2026-05-19 20:05 EST — [iRhythm Holdings to Participate in Upcoming Investor Conferences](https://biopharmsignal.com/news/IRTC/irhythm-holdings-to-participate-in-upcoming-investor-conferences-46a8c364) — Source: iRhythm
- 2026-04-30 20:05 EST — [iRhythm Holdings Announces First Quarter 2026 Financial Results](https://biopharmsignal.com/news/IRTC/irhythm-holdings-announces-first-quarter-2026-financial-results-d2123e7c) — Source: iRhythm
- 2026-04-28 20:05 EST — [iRhythm Holdings to Present at the Bank of America Securities 2026 Health Care Conference](https://biopharmsignal.com/news/IRTC/irhythm-holdings-to-present-at-the-bank-of-america-securities-2026-health-care-c-301062b2) — Source: iRhythm
- 2026-04-27 12:05 EST — [New Data Presented at HRS 2026 Show Short-Term Holter Monitoring Misses a Large Proportion of AF Recurrence Post-Ablation and Clinically Significant Arrhythmias in Pregnancy](https://biopharmsignal.com/news/IRTC/new-data-presented-at-hrs-2026-show-short-term-holter-monitoring-misses-a-large--33898ed4) — Source: iRhythm
## Related News
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)
- 2026-07-29 12:25 EST — ICCM — [IceCure: SIO Petitions NCCN to Include Cryoablation in Breast Cancer Treatment Guidelines, Citing IceCure's FDA Clearance  of ProSense®](https://biopharmsignal.com/news/ICCM/icecure-sio-petitions-nccn-to-include-cryoablation-in-breast-cancer-treatment-gu-bec46cd3)